Age KnockIn Mice Affected by Catecholaminergic Polymorphic Ventricular Tachycardia Is Gene to CASQ 2 Single Delivery of an Adeno-Associated Viral Construct to Transfer the Print

Esposito, Laura Pietrangelo, Isabelle Marty, Laura Villani, Alejandro Moyaho, Paola Baiardi, Giusti, José E. Avelino-Cruz, Nian Liu, Simone Persampieri, Antonio Curcio, Francesca Marco Denegri, Rossana Bongianino, Francesco Lodola, Simona Boncompagni, Verónica C. De Able to Cure the Disease From Birth to Advanced Age Knock-In Mice Affected by Catecholaminergic Polymorphic Ventricular Tachycardia Is Gene to CASQ2 Single Delivery of an Adeno-Associated Viral Construct to Transfer the Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2014 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/CIRCULATIONAHA.113.006901 2014;129:2673-2681; originally published online June 2, 2014; Circulation. http://circ.ahajournals.org/content/129/25/2673 World Wide Web at: The online version of this article, along with updated information and services, is located on the http://circ.ahajournals.org/content/suppl/2014/05/21/CIRCULATIONAHA.113.006901.DC1.html Data Supplement (unedited) at:

[1]  K. Zsebo,et al.  Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure: Analysis of Recurrent Cardiovascular Events and Mortality , 2014, Circulation research.

[2]  Wataru Shimizu,et al.  HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes , 2013 .

[3]  Carlo Napolitano,et al.  Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia , 2013, Circulation research.

[4]  Michael Christiansen,et al.  Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. , 2012, American journal of human genetics.

[5]  Seppo Ylä-Herttuala,et al.  Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  A. Leenhardt,et al.  Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human , 2012, Human molecular genetics.

[7]  S. Priori,et al.  Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias , 2012, Circulation research.

[8]  S. Priori,et al.  Short Communication: Flecainide Exerts an Antiarrhythmic Effect in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia by Increasing the Threshold for Triggered Activity , 2011, Circulation research.

[9]  Silvia G Priori,et al.  Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. , 2011, Circulation research.

[10]  W. Koch,et al.  Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo , 2011, Gene Therapy.

[11]  Alan Garfinkel,et al.  So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. , 2010, Biophysical journal.

[12]  A. Leenhardt,et al.  Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia , 2009, Circulation.

[13]  D. Roden,et al.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans , 2009, Nature Medicine.

[14]  S. Priori,et al.  Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin. , 2008, The Biochemical journal.

[15]  C. Ward,et al.  Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. , 2008, The Journal of clinical investigation.

[16]  José Jalife,et al.  Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia , 2007, Circulation research.

[17]  M. Varsányi,et al.  Characterization of human cardiac calsequestrin and its deleterious mutants. , 2007, Journal of molecular biology.

[18]  M. Viitasalo,et al.  Clinical Research , 2022 .

[19]  J. Wilson,et al.  Efficacy and safety of adeno‐associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy , 2006, Journal of thrombosis and haemostasis : JTH.

[20]  S. Priori,et al.  Clinical Phenotype and Functional Characterization of CASQ2 Mutations Associated With Catecholaminergic Polymorphic Ventricular Tachycardia , 2006, Circulation.

[21]  T. Conlon,et al.  Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo , 2006, Circulation research.

[22]  D. Tester,et al.  Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. , 2006, Heart rhythm.

[23]  S. Priori,et al.  Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor , 2005, Circulation research.

[24]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[25]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[26]  D. Lancet,et al.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. , 2001, American journal of human genetics.

[27]  P. Coumel,et al.  Heart Rate and Heart Rate Variability in Normal Young Adults , 1994, Journal of cardiovascular electrophysiology.